BioMaxima Statistics
Total Valuation
BioMaxima has a market cap or net worth of PLN 53.04 million. The enterprise value is 64.29 million.
Market Cap | 53.04M |
Enterprise Value | 64.29M |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
Earnings Date | Apr 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BioMaxima has 4.19 million shares outstanding. The number of shares has decreased by -4.18% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.19M |
Shares Change (YoY) | -4.18% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 22.38% |
Owned by Institutions (%) | n/a |
Float | 2.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.08 |
PB Ratio | 1.14 |
P/TBV Ratio | 1.15 |
P/FCF Ratio | n/a |
P/OCF Ratio | 11.06 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.52, with an EV/FCF ratio of -12.92.
EV / Earnings | -141.61 |
EV / Sales | 1.31 |
EV / EBITDA | 27.52 |
EV / EBIT | n/a |
EV / FCF | -12.92 |
Financial Position
The company has a current ratio of 1.83, with a Debt / Equity ratio of 0.26.
Current Ratio | 1.83 |
Quick Ratio | 0.78 |
Debt / Equity | 0.26 |
Debt / EBITDA | 5.24 |
Debt / FCF | -2.46 |
Interest Coverage | -0.89 |
Financial Efficiency
Return on equity (ROE) is -0.93% and return on invested capital (ROIC) is -0.67%.
Return on Equity (ROE) | -0.93% |
Return on Assets (ROA) | -0.54% |
Return on Invested Capital (ROIC) | -0.67% |
Return on Capital Employed (ROCE) | -1.03% |
Revenue Per Employee | 425,861 |
Profits Per Employee | -3,948 |
Employee Count | 115 |
Asset Turnover | 0.67 |
Inventory Turnover | 1.92 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.94% in the last 52 weeks. The beta is 0.69, so BioMaxima's price volatility has been lower than the market average.
Beta (5Y) | 0.69 |
52-Week Price Change | -19.94% |
50-Day Moving Average | 13.28 |
200-Day Moving Average | 14.20 |
Relative Strength Index (RSI) | 47.74 |
Average Volume (20 Days) | 8,939 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioMaxima had revenue of PLN 48.97 million and -454,000 in losses. Loss per share was -0.11.
Revenue | 48.97M |
Gross Profit | 22.21M |
Operating Income | -634,000 |
Pretax Income | -852,000 |
Net Income | -454,000 |
EBITDA | 2.19M |
EBIT | -634,000 |
Loss Per Share | -0.11 |
Balance Sheet
The company has 1.00 million in cash and 12.25 million in debt, giving a net cash position of -11.25 million or -2.68 per share.
Cash & Cash Equivalents | 1.00M |
Total Debt | 12.25M |
Net Cash | -11.25M |
Net Cash Per Share | -2.68 |
Equity (Book Value) | 46.60M |
Book Value Per Share | 11.11 |
Working Capital | 10.73M |
Cash Flow
In the last 12 months, operating cash flow was 4.80 million and capital expenditures -9.77 million, giving a free cash flow of -4.98 million.
Operating Cash Flow | 4.80M |
Capital Expenditures | -9.77M |
Free Cash Flow | -4.98M |
FCF Per Share | -1.19 |
Margins
Gross margin is 45.35%, with operating and profit margins of -1.29% and -0.93%.
Gross Margin | 45.35% |
Operating Margin | -1.29% |
Pretax Margin | -1.74% |
Profit Margin | -0.93% |
EBITDA Margin | 4.46% |
EBIT Margin | -1.29% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.39, which amounts to a dividend yield of 3.10%.
Dividend Per Share | 0.39 |
Dividend Yield | 3.10% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 4.18% |
Shareholder Yield | 7.28% |
Earnings Yield | -0.86% |
FCF Yield | -9.38% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BioMaxima has an Altman Z-Score of 2.95. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.95 |
Piotroski F-Score | n/a |